Entrada Therapeutics Funding: $241M Raised, Series A (2018)
Entrada Therapeutics is based in Boston, MA. It has raised $241M in total funding. Latest round: Series A.
Entrada Therapeutics funding overview
Entrada Therapeutics is based in Boston, MA. Entrada Therapeutics has raised $241M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2018. The round record for Entrada Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund, Agent Capital. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Entrada Therapeutics funding
How much has Entrada Therapeutics raised?
Entrada Therapeutics has raised $241M in total disclosed funding across the rounds on record.
Who has invested in Entrada Therapeutics?
5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund, Agent Capital are named among the investors backing Entrada Therapeutics.
What was the latest Entrada Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2018.
Where is Entrada Therapeutics based?
Entrada Therapeutics is based in Boston, MA.
When did Entrada Therapeutics last raise?
The last disclosed Entrada Therapeutics round closed in December 2018 at Series A.
Totals shown for Entrada Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
